Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
CDC23
Introduction
Cell division cycle 23 homolog (S. cerevisiae), also known as CDC23, is a protein that, in humans, is encoded by the CDC23 gene.[1]
Function
Function
The CDC23 protein shares strong similarity with Saccharomyces cerevisiae Cdc23, a protein essential for cell cycle progression through the G2/M transition. This protein is a component of anaphase-promoting complex (APC), which is composed of eight protein subunits and highly conserved in eukaryotic cells. APC catalyzes the formation of cyclin B–ubiquitin conjugate that is responsible for the ubiquitin-mediated proteolysis of B-type cyclins. This protein and 3 other members of the APC complex contain the TPR (tetratricopeptide repeat), a protein domain important for protein-protein interaction.[1]
References
References
- ↑ 1.0 1.1 “Entrez Gene: CDC23 cell division cycle 23 homolog (S. cerevisiae)”.
- ↑ Vodermaier HC, Gieffers C, Maurer-Stroh S, Eisenhaber F, Peters JM (Sep 2003). “TPR subunits of the anaphase-promoting complex mediate binding to the activator protein CDH1”. Current Biology. 13 (17): 1459–68. doi:10.1016/S0960-9822(03)00581-5. PMID 12956947.
- ↑ Gmachl M, Gieffers C, Podtelejnikov AV, Mann M, Peters JM (Aug 2000). “The RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to ubiquitinate substrates of the anaphase-promoting complex”. Proceedings of the National Academy of Sciences of the United States of America. 97 (16): 8973–8. doi:10.1073/pnas.97.16.8973. PMC 16806. PMID 10922056.
External links
External links
- Human CDC23 genome location and CDC23 gene details page in the UCSC Genome Browser.
Further reading
Further reading
- Maruyama K, Sugano S (Jan 1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (Oct 1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Yu H, Peters JM, King RW, Page AM, Hieter P, Kirschner MW (Feb 1998). “Identification of a cullin homology region in a subunit of the anaphase-promoting complex”. Science. 279 (5354): 1219–22. doi:10.1126/science.279.5354.1219. PMID 9469815.
- Zhao N, Lai F, Fernald AA, Eisenbart JD, Espinosa R, Wang PW, Le Beau MM (Oct 1998). “Human CDC23: cDNA cloning, mapping to 5q31, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias”. Genomics. 53 (2): 184–90. doi:10.1006/geno.1998.5473. PMID 9790767.
- Grossberger R, Gieffers C, Zachariae W, Podtelejnikov AV, Schleiffer A, Nasmyth K, Mann M, Peters JM (May 1999). “Characterization of the DOC1/APC10 subunit of the yeast and the human anaphase-promoting complex”. The Journal of Biological Chemistry. 274 (20): 14500–7. doi:10.1074/jbc.274.20.14500. PMID 10318877.
- Gieffers C, Peters BH, Kramer ER, Dotti CG, Peters JM (Sep 1999). “Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons”. Proceedings of the National Academy of Sciences of the United States of America. 96 (20): 11317–22. doi:10.1073/pnas.96.20.11317. PMC 18031. PMID 10500174.
- Gmachl M, Gieffers C, Podtelejnikov AV, Mann M, Peters JM (Aug 2000). “The RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to ubiquitinate substrates of the anaphase-promoting complex”. Proceedings of the National Academy of Sciences of the United States of America. 97 (16): 8973–8. doi:10.1073/pnas.97.16.8973. PMC 16806. PMID 10922056.
- Simpson JC, Wellenreuther R, Poustka A, Pepperkok R, Wiemann S (Sep 2000). “Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing”. EMBO Reports. 1 (3): 287–92. doi:10.1093/embo-reports/kvd058. PMC 1083732. PMID 11256614. Check date values in:
|year= / |date= mismatch(help) - Walker MG (May 2001). “Drug target discovery by gene expression analysis: cell cycle genes”. Current Cancer Drug Targets. 1 (1): 73–83. doi:10.2174/1568009013334241. PMID 12188893. Check date values in:
|year= / |date= mismatch(help) - Wang Q, Moyret-Lalle C, Couzon F, Surbiguet-Clippe C, Saurin JC, Lorca T, Navarro C, Puisieux A (Mar 2003). “Alterations of anaphase-promoting complex genes in human colon cancer cells”. Oncogene. 22 (10): 1486–90. doi:10.1038/sj.onc.1206224. PMID 12629511.
- Vodermaier HC, Gieffers C, Maurer-Stroh S, Eisenhaber F, Peters JM (Sep 2003). “TPR subunits of the anaphase-promoting complex mediate binding to the activator protein CDH1”. Current Biology. 13 (17): 1459–68. doi:10.1016/S0960-9822(03)00581-5. PMID 12956947. Check date values in:
|year= / |date= mismatch(help) - Kraft C, Herzog F, Gieffers C, Mechtler K, Hagting A, Pines J, Peters JM (Dec 2003). “Mitotic regulation of the human anaphase-promoting complex by phosphorylation”. The EMBO Journal. 22 (24): 6598–609. doi:10.1093/emboj/cdg627. PMC 291822. PMID 14657031. Check date values in:
|year= / |date= mismatch(help) - Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villén J, Li J, Cohn MA, Cantley LC, Gygi SP (Aug 2004). “Large-scale characterization of HeLa cell nuclear phosphoproteins”. Proceedings of the National Academy of Sciences of the United States of America. 101 (33): 12130–5. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935.
- Ballif BA, Villén J, Beausoleil SA, Schwartz D, Gygi SP (Nov 2004). “Phosphoproteomic analysis of the developing mouse brain”. Molecular & Cellular Proteomics. 3 (11): 1093–101. doi:10.1074/mcp.M400085-MCP200. PMID 15345747. Check date values in:
|year= / |date= mismatch(help) - Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M (Oct 2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
- Nousiainen M, Silljé HH, Sauer G, Nigg EA, Körner R (Apr 2006). “Phosphoproteome analysis of the human mitotic spindle”. Proceedings of the National Academy of Sciences of the United States of America. 103 (14): 5391–6. doi:10.1073/pnas.0507066103. PMC 1459365. PMID 16565220.
- Beausoleil SA, Villén J, Gerber SA, Rush J, Gygi SP (Oct 2006). “A probability-based approach for high-throughput protein phosphorylation analysis and site localization”. Nature Biotechnology. 24 (10): 1285–92. doi:10.1038/nbt1240. PMID 16964243.
- Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M (Nov 2006). “Global, in vivo, and site-specific phosphorylation dynamics in signaling networks”. Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.